Key Insights

Highlights

Success Rate

91% trial completion (above average)

Published Results

32 trials with published results (6%)

Research Maturity

331 completed trials (66% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.2%

31 terminated out of 504 trials

Success Rate

91.4%

+4.9% vs benchmark

Late-Stage Pipeline

13%

65 trials in Phase 3/4

Results Transparency

10%

32 of 331 completed with results

Key Signals

32 with results91% success31 terminated

Data Visualizations

Phase Distribution

266Total
Not Applicable (140)
Early P 1 (1)
P 1 (25)
P 2 (35)
P 3 (53)
P 4 (12)

Trial Status

Completed331
Unknown62
Recruiting39
Terminated31
Active Not Recruiting14
Withdrawn14

Trial Success Rate

91.4%

Benchmark: 86.5%

Based on 331 completed trials

Clinical Trials (504)

Showing 20 of 20 trials
NCT06046001Not ApplicableCompletedPrimary

AirWaze - Easy and Advanced Tools for CBCT Guided Lung Interventions

NCT05144828Phase 4Completed

Efficacy of Intercostal CryoAnalgesia in Robotic Lung Resection

NCT03626688Phase 3Completed

A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

NCT06836414Not ApplicableWithdrawn

Lung Cancer Screening CT for Firefighters

NCT06373224Not ApplicableTerminatedPrimary

Cold Saline Irrigation Before Endobronchial Biopsy

NCT05525312Not ApplicableRecruitingPrimary

Comparison of Two Strategies of One-lung Ventilation in Patients Undergoing Carcinological Lung Resection Surgery.

NCT05751278Not ApplicableCompletedPrimary

Cryoprobe Versus Forceps for Transbronchial Biopsy

NCT06494033RecruitingPrimary

Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients

NCT06917326Not ApplicableCompleted

Study to Assess Safety and Performance of Neola®, a Novel Lung Monitoring Device for Neonates

NCT05948904Not ApplicableRecruitingPrimary

Defining a Technique for the Use of Cryogenic Catheters for Biopsy and Ablation for the Diagnostic and Treatment of Pulmonary Lesions: An Ex-Vivo Human Lung Model Study.

NCT00201266Completed

Histoblood Group Antigens as a Risk Factor of Asthma

NCT06177717RecruitingPrimary

Deep Functional Phenotyping of the ALA Lung Health Cohort

NCT06975969Withdrawn

Single Center Post-Market Study of Thrombolytic Therapy Using the Versus™ Catheter

NCT04222972Phase 3Terminated

A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT03598309Phase 2Active Not RecruitingPrimary

Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers

NCT06635850Phase 2Active Not Recruiting

A Study of Mosliciguat in PH-ILD

NCT03683186Phase 3Enrolling By Invitation

A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension

NCT06728709Recruiting

Lung Ultrasound in Critically Ill Obstetrics and Gynecological Patients

NCT05922761Phase 2Recruiting

BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)

NCT05907564Not ApplicableActive Not Recruiting

Aventus Thrombectomy System Pulmonary Embolism Clinical Study

Scroll to load more

Research Network

Activity Timeline